Patrick Donnelly
Stock Analyst at Citigroup
(3.71)
# 756
Out of 5,054 analysts
350
Total ratings
52.41%
Success rate
5.99%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Buy | $1,600 → $1,700 | $1,445.06 | +17.64% | 15 | Nov 10, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $313.33 | +19.68% | 17 | Oct 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $315.32 | +18.93% | 17 | Oct 30, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $100 | $97.71 | +2.34% | 10 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $200 → $230 | $218.53 | +5.25% | 13 | Oct 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $500 → $580 | $586.49 | -1.11% | 20 | Oct 23, 2025 | |
| QDEL QuidelOrtho | Downgrades: Neutral | $40 → $33 | $21.89 | +50.75% | 6 | Oct 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $225 → $200 | $163.42 | +22.38% | 10 | Aug 21, 2025 | |
| TECH Bio-Techne | Upgrades: Buy | $55 → $70 | $59.18 | +18.28% | 12 | Aug 21, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $34 → $42 | $25.16 | +66.93% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $38 | $41.73 | -8.94% | 17 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 → $200 | $173.50 | +15.27% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $60 → $80 | $74.60 | +7.24% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $85 → $80 | $122.60 | -34.75% | 17 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $16.59 | -9.58% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $11.50 | +56.52% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $188.85 | -2.04% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $215.79 | +22.80% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $11.81 | +94.83% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $16.13 | +23.99% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $67.50 | +11.11% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $149.42 | +10.43% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $24.17 | +15.85% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $94.31 | +53.75% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $44.22 | +39.76% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $386.14 | -22.31% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.46 | +266.60% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.69 | +2.23% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $268.21 | -3.06% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $8.44 | -28.91% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $6.68 | +379.04% | 2 | Nov 30, 2018 |
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,600 → $1,700
Current: $1,445.06
Upside: +17.64%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $313.33
Upside: +19.68%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $315.32
Upside: +18.93%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $65 → $100
Current: $97.71
Upside: +2.34%
IQVIA Holdings
Oct 29, 2025
Maintains: Neutral
Price Target: $200 → $230
Current: $218.53
Upside: +5.25%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Neutral
Price Target: $500 → $580
Current: $586.49
Upside: -1.11%
QuidelOrtho
Oct 7, 2025
Downgrades: Neutral
Price Target: $40 → $33
Current: $21.89
Upside: +50.75%
ICON Public Limited Company
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $163.42
Upside: +22.38%
Bio-Techne
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $59.18
Upside: +18.28%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $25.16
Upside: +66.93%
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $41.73
Upside: -8.94%
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $173.50
Upside: +15.27%
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $74.60
Upside: +7.24%
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $122.60
Upside: -34.75%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $16.59
Upside: -9.58%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $11.50
Upside: +56.52%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $188.85
Upside: -2.04%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $215.79
Upside: +22.80%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $11.81
Upside: +94.83%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $16.13
Upside: +23.99%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $67.50
Upside: +11.11%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $149.42
Upside: +10.43%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $24.17
Upside: +15.85%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $94.31
Upside: +53.75%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $44.22
Upside: +39.76%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $386.14
Upside: -22.31%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.46
Upside: +266.60%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.69
Upside: +2.23%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $268.21
Upside: -3.06%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $8.44
Upside: -28.91%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $6.68
Upside: +379.04%